NASDAQ IMMY

John Saharek

Chief Commercial Officer

Mr. Saharek started with Imprimis in 2013 and is our Chief Commercial Officer.

Mr. Saharek oversees all of our commercial activities, including strategic planning, marketing, sales, business development, and market access. Mr. Saharek has overseen the launch of Imprimis’s entire ophthalmic portfolio, which now exceeds 30 products in the cataract, refractive, glaucoma and dry eye segments. With this portfolio, Imprimis has experienced a 230% revenue CAGR from 2014-2017. Prior to Imprimis, Mr. Saharek led launches of various pharmaceutical, biotech, surgical device and diagnostic product portfolios at numerous companies, including Roche, Bausch & Lomb and SurModics, Inc., and held marketing and sales positions at a number of other healthcare companies. His results-oriented record of achievement includes designing and executing strategic commercial plans, building strong sustainable brands, launching new products, leading high performing teams and delivering outstanding results for a variety of healthcare companies. Mr. Saharek has a Master’s degree in Business Administration from the University of Hartford and a Bachelor’s degree from Central Connecticut State University.


Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.